Video

Rose Maljanian Says AJMC Is Poised to Help Lead Change in Healthcare

As the healthcare industry moves toward population health and improving quality and value, The American Journal of Managed Care (AJMC) is in a good position to help lead the change, according to Rose Maljanian, RN, MBA, chairman and chief executive officer of HealthCAWS and a member of the AJMC editorial board.

As the healthcare industry moves toward population health and improving quality and value, The American Journal of Managed Care (AJMC) is in a good position to help lead the change, according to Rose Maljanian, RN, MBA, chairman and chief executive officer of HealthCAWS and a member of the AJMC editorial board.

Transcript (slightly modified for readability)

Happy anniversary to AJMC, it's an important, multi-stakeholder movement, not only a high-quality journal, and I'm so pleased to be part of the board.

How has AJMC contributed to the field of managed care over the last 20 years?

AJMC has really been the sole provider of a very broad literature on managed care real-world studies, and having been a co-founder of a delivery system-based institute for outcomes research on evaluation, I really appreciate the real-world approach to the science.

It's important to have a peer-reviewed process that includes the look at methodology and statistical approaches in a real-world setting. Not all of the studies included in this broad literature are randomized trials, and that opens up a whole world of opportunity to share best practices across the nation, and the world.

How will both managed care and AJMC change in the next 20 years?

Well I think the answer to that is for both AJMC and the industry, the movement really is toward population health, improving quality, and improving value, and that means better quality for a reasonable cost and the best value for patients, who we're now referring to as consumers. And managed care is across multi-stakeholder groups: it's payers of all kinds, it's the delivery systems involved in accountable care, and it's the consumers seeking other places of care in the retail world that are really going to require a massive change in how we look at the healthcare delivery system, and moving it more into the lives of consumers and patients.

I think the group, the board, that AJMC has put together really is in a good position to continue to support its members in a way that can lead this change.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Hamlet Gasoyan, PhD
EHA 2025 Congress Recap | Image Credit: Venngage
Coral Omene, MD, PhD, sitting for a vieo interview
Lorna Warwick
Ashley Yocum, PhD
Dr Matthew Matasar
Dr Xavier Leleu
Francesco Sparano, MSc
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo